Keeping you posted: analysis of fertility-related social media posts after introduction of the COVID-19 vaccine: The European Journal of Contraception & Reproductive Health Care: Vol 0, No 0
Abstract
Purpose
Our aim was to examine information and sentiments posted about the COVID-19 vaccine on fertility-related social media.
Materials and Methods
The first fifty accounts on Instagram and Twitter were identified by the terms: fertility doctor, fertility, OBGYN, infertility, TTC, IVF. Accounts are categorized as physician (PH), individual (ID), or fertility center/organization (FCO). The vaccine was approved on 12/11/2020 and Instagram and Twitter posts dated 12/1/2020 − 2/28/2021 were reviewed. Posts were analyzed for sentiment, mention of research studies (RS), national guidelines (NG), personal experience (PE), side effects (SE), reproductive related (RR) content and activities, including likes and comments.
Results
A total of 276 accounts are included. Vaccine feelings were mostly positive (PH 90.3%, ID 71.4%, FCO 70%), or neutral (PH 9.7%, ID 28.6%, FCO 30%). Instagram accounts showed increased activity on vaccine posts compared to baseline according to likes (PH 4.86% v 3.76%*, ID 7.5% v 6.37%*, FCO 2.49% v 0.52%*) and comments ( PH 0.35% v 0.28%, ID 0.90% v 0.69%,* FCO 0.10% v 0.02%*).
Conclusion
Most of the posts expressed positive feelings about the vaccine. Examining fertility-related COVID-19 vaccine sentiment on social media represents an opportunity to understand patient and health care professional opinion on the topic. Because of the potentially harmful effects of misinformation on public health parameters, such as vaccination, social media offers a way for health care professionals to communicate online and work to make it more effective and influential. their presence.
Disclosure statement
No potential conflicts of interest are reported by the author(s).
Reprints and Company Permissions
Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page
How do I view content?
To request reprint or company permissions for this article, please click on the relevant link below:
Academic Permissions
Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page How do I view content?
Get permissions instantly through Rightslink by clicking the button below:
If you are unable to obtain permissions through Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
